Our findings that CD36 is required for lipid uptake and cell migration in REDD1-deficient cells provide new insight into CD36 activation in cancer, and they collectively suggest a direct contribution of CD36 to the pathogenesis of REDD1-deficient tumors. The gene discussed is CD36; the disease is cancer.